PTC Therapeutics Inc’s filing revealed that its SVP, CHIEF ACCOUNTING OFFICER Utter Christine Marie unloaded Company’s shares for reported $44034.0 on Feb 19 ’25. In the deal valued at $50.10 per share,879 shares were sold. As a result of this transaction, Utter Christine Marie now holds 63,442 shares worth roughly $3.17 million.
Then, Utter Christine Marie sold 878 shares, generating $44,009 in total proceeds. Upon selling the shares at $50.12, the SVP, CHIEF ACCOUNTING OFFICER now owns 62,564 shares.
Before that, Gravier Pierre sold 1,168 shares. PTC Therapeutics Inc shares valued at $58,512 were divested by the CHIEF FINANCIAL OFFICER at a price of $50.10 per share. As a result of the transaction, Gravier Pierre now holds 75,603 shares, worth roughly $3.78 million.
Morgan Stanley upgraded its PTC Therapeutics Inc [PTCT] rating to an Overweight from a an Equal-weight in a research note published on December 13, 2024; the price target was increased to $67 from $45. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who increased its forecast for the stock in early December from “a Sector perform” to “an Outperform”. Robert W. Baird started covering the stock on September 04, 2024. It rated PTCT as “an Outperform”.
Price Performance Review of PTCT
On Friday, PTC Therapeutics Inc [NASDAQ:PTCT] saw its stock fall -1.32% to $50.02. Over the last five days, the stock has lost -3.47%. PTC Therapeutics Inc shares have risen nearly 10.81% since the year began. Nevertheless, the stocks have risen 92.83% over the past one year. While a 52-week high of $54.16 was reached on 02/18/25, a 52-week low of $24.00 was recorded on 01/14/25. SMA at 50 days reached $46.91, while 200 days put it at $39.19.
Levels Of Support And Resistance For PTCT Stock
The 24-hour chart illustrates a support level at 49.37, which if violated will result in even more drops to 48.71. On the upside, there is a resistance level at 50.84. A further resistance level may holdings at 51.65. The Relative Strength Index (RSI) on the 14-day chart is 57.05, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.47, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 51.49%. Stochastics %K at 60.87% indicates the stock is a holding.
